IDBI Bank Ltd. announces an acquisition

Verdict: The reported Rs 81 per-share transaction price implies a 12.88x P/B based on IDBI Bank’s latest reported BVPS of Rs 6.29. Using the supplied price observations as a proxy for the last four quarters, this sits within the observed 9.78x–18.44x P/B range, below its midpoint of approximately 14.11x.

The transaction price is therefore:

• 3.10x P/B above the observed low-end valuation of 9.78x.
• 5.56x P/B below the observed high-end valuation of 18.44x.
• Approximately 1.23x below the midpoint of the observed P/B range.
• About 10.39% below the 14 October 2026 closing price of Rs 90.39, using the same Q4 FY26 BVPS.

Important basis caveat: Q1 FY27 BVPS is not shown in the structured series, so Rs 6.29 from Q4 FY26 is the latest reported BVPS available. The 9.78x–18.44x range is a static-BVPS proxy derived from the supplied monthly stock-price range, not a true quarter-by-quarter P/B history using each quarter’s contemporaneous BVPS. The Rs 81 figure remains a reported transaction price and should not be treated as a completed acquisition price solely on the news reports.

^[1][2]

The cited materials do not disclose the definitive agreement’s full conditions-precedent schedule or a calendar long-stop date. Accordingly, the long-stop date for completion of the 60.72% transfer cannot be verified from the available extracts.

The regulatory conditions that are expressly reported are:

• RBI Fit and Proper assessment: The successful bidder must present its credentials to the RBI in accordance with the “Fit and Proper” assessment conducted at the EoI stage. It must also submit a roadmap for complying with the regulatory conditions prescribed as part of that process. ^[3]
• MHA security clearance: Participation in the bidding stage was limited to parties found “Fit and Proper” by the RBI and granted security clearance by the Ministry of Home Affairs. ^[4]
• Other statutory and regulatory approvals: Contemporary reporting identifies approvals from other statutory and regulatory authorities, including the Competition Commission of India, as required before completion. ^[5]

Long-stop date: No specific date is stated in the cited official announcement or extracts. The definitive agreement itself, or a subsequent filing reproducing its conditions-precedent and long-stop provisions, would be required to establish that date.

Post-transaction, the residual government-linked holding is confirmed at 34%: 15% with the Government of India and 19% with LIC. The strategic buyer acquires 60.72%, comprising 30.48% from GoI and 30.24% from LIC. ^[4]

• Government of India: retains a 15% residual stake. It is intended to be monetised through open-market sales under the applicable standard operating procedure. ^[6]
• LIC: retains a 19% residual stake and may manage it under its internal procedures, subject to regulatory directions. ^[6]
• Governance status: both GoI and LIC will withdraw their board nominees and become public shareholders. ^[3]

Lock-in and right of first refusal: The published transaction terms do not specify a fixed lock-in period or a right-of-first-refusal clause for either residual holding. The disclosed mechanism instead refers to GoI’s potential open-market sale and LIC’s freedom to manage its stake under internal procedures. ^[6]

The qualification is important: this establishes what is disclosed in the government’s announcement and FAQ, but the full executed share-purchase agreement is not reproduced in the cited material. Therefore, the precise conclusion is that no lock-in or ROFR term is publicly identified in the disclosed transaction terms, rather than that such provisions are definitively absent from the complete agreement.